Searched for
AUGMENTIN
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Obesity drug Mounjaro becomes India's top-selling drug by value in OctoberEli Lilly's Mounjaro drug has become India's top seller for October as sales reached one billion rupees. This anti-obesity medication helps...
- GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...
- Plant for production of Penicillin G & Clavulanic acid to start soon: Department of PharmaceuticalsThe Department of Pharmaceuticals has announced that India will soon start producing Clavulanic Acid, a key ingredient in the antibiotic Au...
- India starts making key API clavulanic acidIndia has begun producing clavulanic acid, a key ingredient in the antibiotic Augmentin, reducing its reliance on China for APIs. Mumbai-ba...
- Domestic pharmaceutical retail market grows 11 per cent in JulyThe domestic pharmaceutical retail market saw an impressive 11% growth in July, attributed to increased sales of anti-infectives and pain r...
- Pharma market grows 9.5% in JanuaryThe Indian pharmaceutical market (IPM) saw a robust growth of 9.5% in January with all major therapy areas recording double-digit growth. A...
- Indian pharma market grows over 9 per cent in DecemberAmong the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last mont...
- GSK's Augmentin is India's no.1 drug brandResearch firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood...
- Indian pharma market grew 12.1% in August, AWACS reportThe wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on ...
- Indian pharma market grew 14.1% in July, AIOCD reportThe fastest growing categories are respiratory which grew at 22.3%, gynaecology - 24%, chemotherapy - 28.4%, urology - 22.5%, ophthalmic - ...
- Reduce GSK Pharma, target Rs 2483: NomuraHowever, the market expects strong revival in EBITDA margins and the stock is factoring in possible delisting if parent Glaxo Plc buys back...
- Drug companies, distributors slugfest over marginsDrugmakers from GlaxoSmithKline to Lupin are grappling with distributors, whose demand for maintaining commissions threatens to erode profi...
- For cheaper drug options, send SMSYou would soon be able to find the most affordable alternative to the medicine prescribed by your doctor through an SMS-based service.
- Dr Reddy's acquires GSK's US penicillin facilityDr Reddy's Laboratories has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil bran...
- Dr Reddy’s buys GSK’s oral penicillin facility in USDr Reddy’s Laboratories, one of the country’s biggest drug firms, has bought GlaxoSmithKline’s oral penicillin facility and products in the...
- Prices of antibiotics may flare up 50%A government proposal to slap anti-dumping duties on Chinese and Mexican imports of two key pharma ingredients will push up the prices of c...
- Wockhardt climbs 5% on USFDA nodShares of drugmaker Wockhardt rose more than 5 per cent after its subsidiary in the US had won approval from FDA to market augmentin suspen...
- Ranbaxy gets US nod to mkt its drugGurgaon-based pharmaceutical major Ranbaxy Labs today announced that RLL has received approval from the US Food and Drug Administration to ...
Load More
